Potent, Selective CARs as Potential T-Cell Therapeutics for HPV-positive Cancers-Reference-Cited by-同舟云学术

Potent, Selective CARs as Potential T-Cell Therapeutics for HPV-positive Cancers

Published:2021-08-24 Issue:8 Volume:44 Page:292-306
ISSN:1524-9557
Container-title:Journal of Immunotherapy
language:en
Short-container-title:

Author:

Wang Xueyin,Sandberg Mark L.,Martin Aaron D.,Negri Kathleen R.,Gabrelow Grant B.,Nampe Daniel P.,Wu Ming-Lun,McElvain Michele E.,Toledo Warshaviak Dora,Lee Wen-Hua,Oh Julyun,Daris Mark E.,Chai Falene,Yao Christine,Furney James,Pigott Craig,Kamb Alexander,Xu Han

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology,Immunology,Immunology and Allergy

Reference69 articles.

1. Direct observation of ligand recognition by T cells;Irvine;Nature,2002

2. Insights into the initiation of TCR signaling;Chakraborty;Nat Immunol,2014

3. TCR-engineered T cells targeting E7 for patients with metastatic HPV-associated epithelial cancers;Nagarsheth;Nat Med,2021

4. T cells targeting carcinoembryonic antigen can mediate regression of metastatic colorectal cancer but induce severe transient colitis;Parkhurst;Mol Ther,2011

5. Cancer regression and neurological toxicity following anti-MAGE-A3 TCR gene therapy;Morgan;J Immunother,2013

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. VIPER-TACs leverage viral E3 ligases for disease-specific targeted protein degradation;2024-08-16

2. NOT gated T cells that selectively target EGFR and other widely expressed tumor antigens;iScience;2024-06

3. Final outcomes analysis of the cell product SQZ‐PBMC‐HPV Phase 1 trial in incurable HPV16+ solid tumors shows improved overall survival in patients with increased CD8+ T cell tumor infiltration;Molecular Carcinogenesis;2024-05-02

4. Beyond Viral Infections: The Multifaceted Roles of Human Papillomavirus and Epstein-Barr Virus in Shaping the Tumor Microenvironment;Discovery Medicine;2024

5. Human papillomavirus associated cervical lesion: pathogenesis and therapeutic interventions;MedComm;2023-09-14